Focal Segmental Glomerulosclerosis (FSGS) Market is Expected to Witness Significant Growth by 2034 Owing to the Launch of Novel Targeted Therapies | DelveInsight

Source Summary

The market dynamics for Focal Segmental Glomerulosclerosis (FSGS) are anticipated to witness notable growth driven by increasing disease awareness, rising diagnosis rates, growing understanding of genetic and podocyte-related disease mechanisms, and the emergence of targeted treatment approaches. Additionally, the expected